a bit early but could be good news for us17 Apr 2020 17:41
(Bloomberg) -- Moderna soared after getting $483 million in U.S. funding for a potential coronavirus vaccine, and Gilead jumped on a report that a group of patients being treated with its experimental drug were seeing rapid recoveries.